What Do You Need To Know About Imatinib®

What do you need to know about Imatinib® (Generic Gleevec)?

Ask Marley Drug

Generic Imatinib: Gaining Perspective

The Life Raft Group

Overview of Gleevec the Brand Name Form of Imatinib

Dr. Pamela Crilley on Imatinib and Second Generation TKIs

Targeted Oncology

What is Imatinib?

Silver MPN Center

Dr. Jerald Radich on Impact of Generic Imatinib in CML

Imatinib, where are we now? What about generic Imatinib? Dr Joanne Ewing

CML Support Group UK

Spotlight on APL, CML, and multiple myeloma

Novel agents or imatinib for CML in the frontline setting?

VJHemOnc – Video Journal of Hematology & HemOnc

Starting first-line treatment, update on Imatinib.

CML Support Group UK

Dr. Jerald P. Radich on Treatment Considerations with Generic Imatinib in CML

CML Patient Video: What You Need to Know About Side Effects and How to Manage Them

Spotlight on Testing: Imatinib Mesylate

ARUP Laboratories

Brian Druker (OHSU) Part 1: Imatinib (Gleevec): A Targeted Cancer Therapy

Science Communication Lab

Medicine 9354 Imatinib mesylate CML treatment Chronic Myeloid Leukemia cancer drug

The cancer curing drug you have probably never heard of: Imatinib

Highly Entropic Mind

Chronic Myeloid Leukemia (CML): What to do if I experience side effects?

Leukemia & Lymphoma Society

What are the efficacy and safety considerations of imatinib therapy?

MediCom Oncology

Strategies in Chronic Myeloid Leukemia: The Evolving Treatment Landscape

Multidisciplinary management of chronic myeloid leukaemia in the later-line setting

Touch Medical Media